Tsinghua University

Boe Technology Group Co., Ltd.

Beijing Boe Optoelectronics Technology Co., Ltd.

Hon Hai Precision Industry Co., Ltd.

International Business Machines Corporation

Shanghai Zhaoxin Semiconductor Co., Ltd.

Juniper Networks, Inc.

Beijing Boe Display Technology Co., Ltd.

Beijing Boe Technology Development Co., Ltd.

General Electric Company

Chengdu Boe Optoelectronics Technology Co., Ltd.

Huazhong University of Science and Technology

Beijing Boe Sensor Technology Co., Ltd.

Beijing Didi Infinity Technology and Development Co., Ltd.

China Agricultural University

Wei Zhao

Songling Huang

Shou-Shan Fan

Kai-Li Jiang

Jian Wang

Peng Liu

Yu Zhang

Xiaojuan Wu

Xiao-Yang Lin

Hongliang Yuan

Zongpu Qi

Li Tian

Duan-Liang Zhou

Chunlei Wang

Chun-Hai Zhang

Jiaxing Wang

Xiao Guang Rui

Jinshuai Duan

Lei Wang

Wen Jun Yin

Jin Zhang

Na Li

Yao Bi

Xin Xin Bai

Xiaoyang Li

Jun Zhu

Tao Li

Chen Chen

Jiang-Tao Wang

Liping Lei

Hao Yan

Yang Wei

Ying Liu

Zheng Wang

Chao Zhang

Zhe Wang

Gang Hua

Jin Dong

Yu Xin Zhao

Rama Kalyani T Akkiraju

Xinli Ma

Dongchuan Chen

Pankaj Dhoolia

Rakesh Mohan

Kaixuan Wang

Jian Lin

Lu Chen

Ming Xie

Cuiwei Tang

Bingyang Liu

Limin Zhang

Zhichao Yang

Zhilong Duan

Yashuai An

Xianglei Qin

Honggui Jin

Lingfang Nie

Liangzhen Tang

Yue Wang

Dong Chen

Wenqing Zhao

Xi Chen

Yue Long

Hailin Xue

Jia-Ping Wang

Bo Liu

Xin Zhou

Ning Duan

Jing Yu

Chuncheng Che

Wei Shan Dong

Qing Fa Wang

Ling Wang

Rui Ma

Shao Chun Li

Yong Yang

Ming Lei

Min Gong

Yu Ying Wang

He Huang

Qi Chen

Qi Zheng

Bo Shi

Chao Xue

Hui Du

Hua Fang Tan

Junchi Yan

Rowland F Saunders

Xue Cao

Lin Liu

Yanchen Li

Ying Huang

Jianyun Xie

Qi Ming Tian

Gang Zhou

Xuan Zhong

Zhiqiang Zhao

Zhifeng Zhang

Shuai Han

The present disclosure pertains to the field of biomedical materials, and in particular relates to a medical hydrogel, a preparation method and uses thereof, and a kit for preparing the medical hydrogel. The medical hydrogel of the present disclosure comprises a hydrogel skeleton, and a chelating agent chelated to the hydrogel skeleton; wherein the hydrogel skeleton comprises a polymer that is formed by the bonding of a polyethylene glycol derivative I having a structure shown in Formula (I) and a polyethylene glycol derivative II having a structure shown in Formula (II) and has multiple 'long arms'. After tannic acid and/or citric acid as a chelating agent chelates with the hydrogel skeleton, a medical hydrogel can be obtained, which has good bacteriostatic properties, mechanical properties, adhesion properties, low swelling properties, and controllable gel formation rate and degradation rate. Moreover, the hydrogel is able to maintain viscosity in a wet state without being affected by body fluids, and it can still ensure effective adhesion and closure of wounds if there is movement or pulsation of the tissue, thus having great clinical application prospects.

Medical hydrogel and preparation method and uses thereof

A liquid crystal display panel is provided. The liquid crystal display panel includes: a first substrate and a second substrate arranged opposite to each other, and a liquid crystal layer and a plurality of strip-shaped spacers disposed between the first substrate and the second substrate. In the liquid crystal display panel, there is an overlapping area between an orthographic projection of a first signal line on a target base and an orthographic projection of a second signal line on the target base, and an orthographic projection of the strip-shaped spacer on the target base is not overlapped with the overlapping area.

Liquid crystal display panel and electronic paper

The disclosure relates to the field of biology and provides a breeding method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance, which comprises administrating N-acetylcysteine and vitamin A prior to the exogenous gonadotropin treatment. The disclosure can effectively improve the reproductive performance, including improving the uterine receptivity and pregnancy outcome after exogenous gonadotropins treatment, such as embryo implantation rate, the status of embryo development after implantation, pregnancy rate, live birth, health condition of born offspring, and other effects, by using a combination of N-acetylcysteine and vitamin A. Moreover, the combination of N-acetylcysteine and vitamin A has synergistic effect and has a wide application prospect, for example, in animal husbandry to realize the reproduction regulation and control management of animals including domestic animals such as pigs, horses, cattle, and the like and realize batch production, as well as in the field of assisted reproduction, with high application value.

Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance

A dual-frequency antenna and an electronic device are provided, and belong to the field of communication technology. The dual-frequency antenna includes a first antenna unit and a second antenna unit opposite to each other, and a filtering unit therebetween. An operating frequency band of the first antenna unit is a first frequency band; an operating frequency band of the second antenna unit is a second frequency band; the filtering unit is configured to reflect an electromagnetic wave of the first frequency band and to transmit an electromagnetic wave of the second frequency band; the first antenna unit is configured to receive the electromagnetic wave of the first frequency band and to reflect the received electromagnetic wave of the first frequency band by the filtering unit; and the second antenna unit is configured to receive and reflect the electromagnetic wave of the second frequency band transmitted by the filtering unit.

Dual-frequency antenna and electronic device

The embodiments of the present disclosure provide a display substrate, a display panel, and a display device. The display substrate includes: a first base substrate, wherein a plurality of sub-pixel regions arranged in an array are provided on the first base substrate; and a reflective layer provided on one side of the first base substrate, wherein a surface of the reflective layer away from the first base substrate is formed to include a plurality of first bumps and a plurality of second bumps, and the first bump has a size greater than that of the second bump.

Display substrate, display panel, and display device

Provided are an antenna structure, an array antenna and an electronic device. The antenna structure includes a first substrate, a second substrate and a dielectric layer with an adjustable dielectric constant. The first substrate includes a first base and a first and a second radiation phase shift unit. The second substrate includes a second base and a third and a fourth radiation phase shift unit. Orthographic projections of the first and third radiation phase shift units on the first base at least partially overlap. Orthographic projections of the second and fourth radiation phase shift units on the first base at least partially overlap. A first included angle is formed between extending directions of radiation areas of the first and second radiation phase shift units; a second included angle is formed between extending directions of radiation areas of the third and fourth radiation phase shift units.

Antenna structure, array antenna and electronic device

A use of baicalin in preparation of a drug for treating a tumor irresponsive to immune checkpoint inhibitors (ICIs)/undergoing hyperprogression is provided, where the non-response to ICIs/hyperprogression of the tumor is caused by excessive Foxp3Treg cells; the targeted tumor is one selected from the group consisting of melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), liver cancer, colorectal cancer (CRC), urothelial bladder cancer, and pancreatic cancer; and the ICIs is one or a mixture of two or more selected from the group consisting of a PD-1 inhibitor, a PD-L1 inhibitor, and a CTLA-4 inhibitor. In the present disclosure, baicalin is used in combination with ICIs to inhibit a number of Foxp3Treg cells in a tumor to play an anti-tumor sensitization effect, which can effectively treat a variety of tumors irresponsive to ICIs/undergoing hyperprogression caused by excessive Foxp3Treg cells.

Use of baicalin in preparation of drug for treating tumor irresponsive to immune checkpoint inhibitors (ICIs)/undergoing hyperprogression

A training method () and system for a collimator border detection method. The training method () comprises the following steps: obtaining an original image acquired by an X-ray imaging system and a processed image obtained after processing the original image (); determining on the basis of the processed image whether the processed image is a valid image (); and extracting coordinates of a collimator border of a valid processed image, putting into a training pool the extracted coordinates of the collimator border and the original image corresponding to the valid processed image, and when the number of valid original images in the training pool reaches a preset threshold value, starting the training of the collimator border detection method ().

Training method and system for collimator border detection method

The present disclosure provides a display device including: a display panel having a display region and a peripheral region surrounding the display region, the display panel including: an array substrate, an opposite substrate and a liquid crystal layer, wherein the array substrate and the opposite substrate are opposite to each other, the liquid crystal layer is between the array substrate and the opposite substrate, a light shielding layer is on a side of at least one of the array substrate and the opposite substrate proximal to the liquid crystal layer, and an orthographic projection of the light shielding layer on the array substrate is located in the peripheral region; and a light source configured to emit light to a lateral side of the display panel, the light being incident into the liquid crystal layer from the lateral side of the display panel.

Display device

A device may receive information associated with a service chain to be implemented in association with a flow. The information associated with the service chain may include a source network address associated with the flow, a destination network address associated with the flow, a set of protocols associated with the flow, and a set of network services, of the service chain, to be implemented in association with the flow. The device may implement the service chain in association with the flow. The device may receive network traffic information associated with the flow based on implementing the service chain in association with the flow. The device may modify the service chain based on the network traffic information associated with the flow to permit a modified service chain to be implemented in association with the flow.

Dynamically modifying a service chain based on network traffic information

The present disclosure provides a light-adjusting glass and a manufacturing method thereof, and a glass assembly, and belongs to the field of display glass technology. The light-adjusting glass of the present disclosure includes at least one light-adjusting module; the light-adjusting module includes a first substrate and a second substrate opposite to each other, and a dye liquid crystal layer between the first substrate and the second substrate; wherein liquid crystal molecules in the dye liquid crystal layer deflect under a control of an electric field between the first substrate and the second substrate, to control a transmittance of light; wherein the dye liquid crystal layer includes a polymer network, which is configured such that when the electric field between the first substrate and the second substrate changes, twisting degrees of the liquid crystal molecules are identical, and twisting degrees of dye molecules are identical.

Light-adjusting glass, manufacturing method thereof and glass assembly

The present disclosure provides an optical assembly, a liquid crystal display device, and an electronic equipment. The optical assembly includes: a linear polarizer, a half-wave plate, and a quarter-wave plate stacked in sequence. An absorption axis of the linear polarizer is substantially perpendicular to a first direction, and the first direction is parallel to a surface of the linear polarizer; an angle between an in-plane slow axis of the half-wave plate and the first direction is in a range of 100&#xb0; to 110&#xb0;; an angle between an in-plane slow axis of the quarter-wave plate and the first direction is in a range of 160&#xb0; to 170&#xb0;.

Optical assembly, liquid crystal display device, and electronic equipment

Growing community of inventors

Beijing, China

Wei Zhao